BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 17631638)

  • 1. Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer.
    Müller MW; Giese NA; Swiercz JM; Ceyhan GO; Esposito I; Hinz U; Büchler P; Giese T; Büchler MW; Offermanns S; Friess H
    Int J Cancer; 2007 Dec; 121(11):2421-33. PubMed ID: 17631638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas.
    Higgins DMO; Caliva M; Schroeder M; Carlson B; Upadhyayula PS; Milligan BD; Cheshier SH; Weissman IL; Sarkaria JN; Meyer FB; Henley JR
    BMC Cancer; 2020 Dec; 20(1):1213. PubMed ID: 33302912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of the semaphorin 3A pathway in prostatic cancer.
    Yacoub M; Coulon A; Celhay O; Irani J; Cussenot O; Fromont G
    Histopathology; 2009 Oct; 55(4):392-8. PubMed ID: 19817889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plexin A1 signaling confers malignant phenotypes in lung cancer cells.
    Yamada D; Watanabe S; Kawahara K; Maeda T
    Biochem Biophys Res Commun; 2016 Nov; 480(1):75-80. PubMed ID: 27717823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cell-derived semaphorin 3A inhibits filopodia formation by blood vascular tip cells.
    Ochsenbein AM; Karaman S; Proulx ST; Berchtold M; Jurisic G; Stoeckli ET; Detmar M
    Development; 2016 Feb; 143(4):589-94. PubMed ID: 26884395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin 3A lytic hybrid peptide binding to neuropilin-1 as a novel anti-cancer agent in pancreatic cancer.
    Ueyama H; Horibe T; Nakajima O; Ohara K; Kohno M; Kawakami K
    Biochem Biophys Res Commun; 2011 Oct; 414(1):60-6. PubMed ID: 21945444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the plexin-A2 receptor in Sema3A and Sema3B signal transduction.
    Sabag AD; Smolkin T; Mumblat Y; Ueffing M; Kessler O; Gloeckner CJ; Neufeld G
    J Cell Sci; 2014 Dec; 127(Pt 24):5240-52. PubMed ID: 25335892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.
    Bouvrée K; Brunet I; Del Toro R; Gordon E; Prahst C; Cristofaro B; Mathivet T; Xu Y; Soueid J; Fortuna V; Miura N; Aigrot MS; Maden CH; Ruhrberg C; Thomas JL; Eichmann A
    Circ Res; 2012 Aug; 111(4):437-45. PubMed ID: 22723296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas.
    Barresi V; Tuccari G
    Neuropathology; 2010 Oct; 30(5):537-46. PubMed ID: 20337947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.
    Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE
    Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of semaphorin 3A and its receptors during mouse corneal development.
    Ko JA; Mizuno Y; Yanai R; Chikama T; Sonoda KH
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):305-9. PubMed ID: 21075075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated Macrophages.
    Wallerius M; Wallmann T; Bartish M; Östling J; Mezheyeuski A; Tobin NP; Nygren E; Pangigadde P; Pellegrini P; Squadrito ML; Pontén F; Hartman J; Bergh J; De Milito A; De Palma M; Östman A; Andersson J; Rolny C
    Cancer Res; 2016 Jun; 76(11):3166-78. PubMed ID: 27197153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SEMA3A partially reverses VEGF effects through binding to neuropilin-1.
    Palodetto B; da Silva Santos Duarte A; Rodrigues Lopes M; Adolfo Corrocher F; Roversi FM; Soares Niemann F; Priscila Vieira Ferro K; Leda Figueiredo Longhini A; Melo Campos P; Favaro P; Teresinha Olalla Saad S
    Stem Cell Res; 2017 Jul; 22():70-78. PubMed ID: 28636974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semaphorin and neuropilin co-expression in motoneurons sets axon sensitivity to environmental semaphorin sources during motor axon pathfinding.
    Moret F; Renaudot C; Bozon M; Castellani V
    Development; 2007 Dec; 134(24):4491-501. PubMed ID: 18039974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semaphorin 3A is expressed in human osteoarthritic cartilage and antagonizes vascular endothelial growth factor 165-promoted chondrocyte migration: an implication for chondrocyte cloning.
    Okubo M; Kimura T; Fujita Y; Mochizuki S; Niki Y; Enomoto H; Suda Y; Toyama Y; Okada Y
    Arthritis Rheum; 2011 Oct; 63(10):3000-9. PubMed ID: 21953086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sema3A and neuropilin-1 expression and distribution in rat white adipose tissue.
    Giordano A; Cesari P; Capparuccia L; Castellucci M; Cinti S
    J Neurocytol; 2003 May; 32(4):345-52. PubMed ID: 14724377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Potential Role of Semaphorin 3A during Orthodontic Tooth Movement.
    Şen S; Lux CJ; Erber R
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages.
    Ji JD; Park-Min KH; Ivashkiv LB
    Hum Immunol; 2009 Apr; 70(4):211-7. PubMed ID: 19480842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor.
    Bagnard D; Vaillant C; Khuth ST; Dufay N; Lohrum M; Puschel AW; Belin MF; Bolz J; Thomasset N
    J Neurosci; 2001 May; 21(10):3332-41. PubMed ID: 11331362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.